Kivicort 6mg Tablet contains Deflazacort, a synthetic glucocorticoid with potent anti-inflammatory and immunosuppressive properties. It is primarily indicated for the treatment of various inflammatory and autoimmune conditions, including rheumatoid arthritis, systemic lupus erythematosus, allergic disorders, and certain dermatological diseases. Deflazacort exerts its therapeutic effects by modulating the immune response and inhibiting the release of pro-inflammatory mediators, thereby reducing inflammation, swelling, and pain. The 6mg dosage provides an effective anti-inflammatory action with a relatively favorable safety profile compared to other corticosteroids. Kivicort is also utilized in managing chronic conditions requiring long-term corticosteroid therapy, as well as in certain cases of respiratory disorders and hematologic diseases. It is essential to use this medication under strict medical supervision due to potential side effects such as immunosuppression, hyperglycemia, osteoporosis, and adrenal suppression. Dosage adjustments and gradual tapering are recommended to minimize withdrawal symptoms and adverse effects. Patients should be monitored regularly for clinical response and any signs of corticosteroid-related complications. Kivicort 6mg Tablet offers a reliable therapeutic option for controlling inflammation and modulating immune function in diverse clinical scenarios.